X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8179) 8179
Book Review (1752) 1752
Publication (442) 442
Conference Proceeding (116) 116
Book Chapter (95) 95
Dissertation (19) 19
Magazine Article (9) 9
Book / eBook (3) 3
Paper (3) 3
Data Set (2) 2
Journal / eJournal (2) 2
Technical Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5641) 5641
atypical antipsychotics (5215) 5215
humans (4652) 4652
psychiatry (4110) 4110
schizophrenia (3898) 3898
male (3177) 3177
pharmacology & pharmacy (2801) 2801
female (2595) 2595
antipsychotic agents - therapeutic use (2551) 2551
neurosciences (2174) 2174
adult (2005) 2005
antipsychotic agents - adverse effects (1882) 1882
schizophrenia - drug therapy (1820) 1820
olanzapine (1708) 1708
risperidone (1541) 1541
middle aged (1490) 1490
clozapine (1459) 1459
double-blind (1386) 1386
clinical neurology (1357) 1357
animals (1309) 1309
haloperidol (1083) 1083
antipsychotic drugs (1071) 1071
antipsychotic agents - pharmacology (982) 982
treatment outcome (918) 918
atypical antipsychotic-drugs (883) 883
rats (879) 879
antipsychotics (876) 876
bipolar disorder (853) 853
aged (832) 832
adolescent (822) 822
drugs (785) 785
antipsychotic agents - administration & dosage (765) 765
drug therapy (749) 749
atypical antipsychotic (714) 714
psychotropic drugs (709) 709
quetiapine (658) 658
dopamine (630) 630
dose-response relationship, drug (608) 608
aripiprazole (578) 578
psychotic disorders - drug therapy (576) 576
analysis (557) 557
neuroleptics (556) 556
risk factors (550) 550
efficacy (544) 544
young adult (518) 518
risperidone - therapeutic use (510) 510
psychosis (498) 498
psychiatric status rating scales (493) 493
antipsychotic (488) 488
risk (473) 473
benzodiazepines - therapeutic use (459) 459
quetiapine fumarate (447) 447
mental disorders (433) 433
bipolar disorder - drug therapy (428) 428
rats, sprague-dawley (428) 428
schizoaffective disorder (420) 420
schizophrenic psychology (412) 412
depression (408) 408
prevalence (405) 405
metabolic syndrome (399) 399
time factors (397) 397
weight-gain (395) 395
antidepressants (394) 394
care and treatment (388) 388
dementia (383) 383
retrospective studies (379) 379
psychopharmacology (375) 375
serotonin (371) 371
double-blind method (368) 368
clozapine - pharmacology (367) 367
benzodiazepines - adverse effects (360) 360
research (360) 360
risperidone - adverse effects (353) 353
comorbidity (341) 341
drug therapy, combination (341) 341
placebo-controlled trial (341) 341
induced weight-gain (339) 339
prefrontal cortex (338) 338
schizophrenic-patients (337) 337
child (333) 333
medicine & public health (331) 331
brain (325) 325
dosage and administration (324) 324
negative symptoms (323) 323
clozapine - therapeutic use (320) 320
atypical neuroleptics (314) 314
placebo (306) 306
weight gain (300) 300
dibenzothiazepines - therapeutic use (299) 299
pharmacology (299) 299
tardive-dyskinesia (298) 298
haloperidol - pharmacology (294) 294
internal medicine (294) 294
health aspects (293) 293
medicine, general & internal (293) 293
antipsychotic-drugs (292) 292
obesity (292) 292
2nd-generation antipsychotics (288) 288
children (287) 287
piperazines - therapeutic use (286) 286
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7744) 7744
German (192) 192
French (143) 143
Spanish (76) 76
Turkish (59) 59
Italian (42) 42
Russian (22) 22
Portuguese (20) 20
Czech (16) 16
Polish (15) 15
Dutch (13) 13
Japanese (10) 10
Chinese (7) 7
Korean (6) 6
Serbian (3) 3
Slovak (3) 3
Croatian (2) 2
Icelandic (2) 2
Persian (2) 2
Slovenian (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CANADIAN FAMILY PHYSICIAN, ISSN 0008-350X, 05/2018, Volume 64, Issue 5, pp. E232 - E233
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 11, pp. 1976 - 1982
We performed a systematic review and Bayesian network meta-analysis to determine atypical antipsychotics that are effective and safe for the treatment of... 
Journal Article
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, ISSN 0720-4299, 12/2015, Volume 83, Issue 12, pp. 665 - 675
Journal Article
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 10/2013, Volume 70, Issue 10, pp. 1067 - 1075
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 05/2015, Volume 72, Issue 5, pp. 438 - 445
IMPORTANCE: Antipsychotic medications are associated with increased mortality in older adults with dementia, yet their absolute effect on risk relative to no... 
MORTALITY | MEDICATIONS | METAANALYSIS | EFFICACY | PSYCHIATRY | ALZHEIMERS-DISEASE | NEUROPSYCHIATRIC SYMPTOMS | OLDER-ADULTS | DRUGS | PLACEBO-CONTROLLED TRIALS | ATYPICAL ANTIPSYCHOTICS | United States - epidemiology | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Male | Risk | Case-Control Studies | Dose-Response Relationship, Drug | Psychotropic Drugs - adverse effects | Dibenzothiazepines - adverse effects | Risperidone - adverse effects | Female | Registries | Retrospective Studies | Dementia - drug therapy | Quetiapine Fumarate | Veterans - psychology | Psychotropic Drugs - administration & dosage | Haloperidol - adverse effects | Dementia - mortality | Antipsychotic Agents - administration & dosage | Aged | Benzodiazepines - adverse effects | Veterans - statistics & numerical data | Antidepressive Agents - adverse effects | Dosage and administration | Antipsychotic drugs | Mortality | Analysis | Risk factors | Dementia | Veterans | Comorbidity | Americans | Survivors | Outpatient Treatment | Longitudinal Study | Psychiatric Disorders | Epidemiology | Benzodiazepines | Conventional Antipsychotics | Anticonvulsants | Cognitive Disorders | Etiology | Psychopharmacology | Opioids | Aging | Antidepressant Drugs | Atypical Antipsychotics | PTSD (ICD-9) | Negative Therapeutic Reaction | Index Medicus | Abridged Index Medicus
Journal Article
Atypical antipsychotics in treatment of bipolar disorderin special populations, 12/2004
Atypical antipsychotics have increased usage during the last decades.While they were used in treatment resistant schizophrenia patients at thebeginning, they... 
bipolar disorder, pregnancy, breast-feed, elderly, child, adolescent, atypical antipsychotic, clozapine, risperidone, olanzapine, quetiapine | Pharmacology | Psychiatry
Journal
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, ISSN 1463-9076, 07/2019, Volume 21, Issue 28, pp. 15463 - 15470
Effective treatment of disorders of the central nervous system can often be achieved using bioactive molecules of similar moieties to those known to be... 
MECHANISM | QUETIAPINE | NEUTRON-SCATTERING | DRUGS | PHYSICS, ATOMIC, MOLECULAR & CHEMICAL | CHEMISTRY, PHYSICAL | RAMAN | POINTS | ATYPICAL ANTIPSYCHOTICS | ARIPIPRAZOLE | Index Medicus
Journal Article
YAKUGAKU ZASSHI, ISSN 0031-6903, 2017, Volume 137, Issue 1, pp. 111 - 120
Typical antipsychotics are easily expressed as adverse events such as extrapyramidal symptom (EPS). On the other hand, incidence of adverse events due to... 
Japanese Adverse Drug Event Report database | atypical antipsychotics | typical antipsychotics | extrapyramidal symptom | reporting odds ratio
Journal Article